サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：再灌流療法市場：治療タイプ別、損傷タイプ別、流通チャネル別、地域別：規模、シェア、展望、機会分析、2023～2030年
市場調査レポート
商品コード
1350237

再灌流療法市場：治療タイプ別、損傷タイプ別、流通チャネル別、地域別：規模、シェア、展望、機会分析、2023～2030年

Reperfusion Treatment Market, By Treatment Type, By Injury Type, By Distribution Channel, and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日
ページ情報
英文 144 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.28円
再灌流療法市場：治療タイプ別、損傷タイプ別、流通チャネル別、地域別：規模、シェア、展望、機会分析、2023～2030年
出版日: 2023年08月16日
発行: Coherent Market Insights
ページ情報: 英文 144 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の再灌流療法市場は、2023年には15億4,670万米ドルになると推定・予測され、予測期間（2023-2030年）のCAGRは4.7%となる見込みです。

レポート対象範囲 レポート詳細
基準年 2022 2023年の市場規模 15億4,670万米ドル
過去データ 2018年から2021年 予測期間 2023-2030
予測期間2023年～2030年 CAGR： 4.70% 2030年の価値予測 21億3,580万米ドル
Reperfusion Treatment Market-IMG1

再灌流療法は、心臓発作後に閉塞した動脈の血流を回復させるために用いられます。再灌流障害は通常、臓器移植やその他の傷害の結果として起こる。患者には抗血小板療法，観血的または血管内再灌流療法，冠動脈形成術などが行われます。再灌流障害は心臓、腎臓、肝臓、腸、肺、脳などの臓器で起こりうる。再灌流障害を治療するための薬剤の臨床試験が行われています。血液供給が不足した結果、組織に損傷が生じると再灌流障害が起こる。脳卒中後の脳損傷は再灌流障害の一例です。再灌流療法は、組織に血液を流入させ、炎症や酸化ストレスによる酸化的損傷を引き起こします。治療的低体温療法、硫化水素療法、シクロスポリン、幹細胞療法などが再灌流障害の治療に用いられます。酸化損傷は再灌流療法が遅れると起こる。

市場力学

主要市場プレイヤーによる新製品の発売や合併・買収の増加は、世界の再灌流療法市場の成長を促進すると予想されます。例えば、2021年10月15日、教育利得者のための広範なプラットフォームであるStudy.comは、灌流として知られる体内組織に酸素を含んだ血液を供給するプロセスを説明する記事を発表しました。医師は、灌流がいつ起こるのかを理解するために、まず心拍周期に関するいくつかの用語を定義しなければならないです。1回の心拍には2つの周期があります。最初のサイクルは「ルブ」または収縮期と呼ばれ、心室が収縮して血液が動脈に送り込まれるときに起こる。第2のサイクルは「ダブ」または拡張期とも呼ばれ、心室が弛緩して血液が充満するときです。

この研究の主な特徴

  • 本レポートは世界の再灌流療法市場を詳細に分析し、2022年を基準年とした予測期間（2023-2030年）の市場規模および複合年間成長率（CAGR）を提供しています。
  • また、異なるセグメントにわたる潜在的な収益機会を解明し、この市場に対する魅力的な投資提案のマトリックスについて説明しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要ハイライト、財務実績、戦略などのパラメータに基づいて、世界の再灌流療法市場における主要企業をプロファイルしています。
  • 本調査の対象となる主要企業には、Corline Biomedical AB, SBI Holdings Inc., Pharming Group NV, Mallinckrodt Pharmaceuticals, MIFCOR, Inc., CFM Pharma Holding B.V, Balmes Transplantation SAS, Revive Therapeutics Ltd, Faraday Pharmaceuticals, Radikal Therapeutics Inc, Amyndas Pharmaceuticals, com, Inc, Angion Biomedica Corp, Young Therapeutics, LLC, Ischemix, Stealth Biotherapeutics Inc, and Bolder Bio Technology Incが含まれます。
  • 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • 世界の再灌流療法市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
  • 利害関係者は世界の再灌流療法市場の分析に使用される様々な戦略マトリックスを通して意思決定が容易になります。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場概況

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 最近の製品上市
  • 疫学
  • 合併、買収、提携
  • 規制シナリオ
  • 主な発展
  • PEST分析

第4章 世界の再灌流療法市場-COVID-19影響分析

  • 経済的影響
  • COVID-19疫学
  • 需給への影響

第5章 再灌流療法の世界市場：治療タイプ別、2018-2030年

  • 治療的低体温療法
  • シクロスポリン
  • 幹細胞治療
  • 硫化水素治療
  • その他

第6章 再灌流療法の世界市場：損傷タイプ別、2018年～2030年

  • 心臓損傷
  • 腎臓損傷
  • 腸損傷
  • その他

第7章 再灌流療法の世界市場：流通チャネル別、2018年～2030年

  • 病院薬局
  • 小売薬局
  • その他

第8章 再灌流療法の世界市場：地域別、2018年-2030年

  • 北米
  • 米国
  • カナダ
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ
  • 欧州
  • 英国
  • ドイツ
  • イタリア
  • フランス
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • ASEAN
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
  • 中東
  • GCC
  • イスラエル
  • その他中東
  • アフリカ
  • 北アフリカ
  • 中央アフリカ
  • 南アフリカ

第9章 競合情勢

  • Corline Biomedical AB
  • SBI Holdings Inc.
  • Pharming Group NV
  • Mallinckrodt Pharmaceuticals
  • MIFCOR, Inc.
  • CFM Pharma Holding B.V
  • Balmes Transplantation SAS
  • Revive Therapeutics Ltd
  • Faraday Pharmaceuticals
  • Radikal Therapeutics Inc
  • Amyndas Pharmaceuticals, com, Inc.
  • Angion Biomedica Corp
  • Young Therapeutics, LLC
  • Ischemix
  • Stealth Biotherapeutics Inc
  • Bolder Bio Technology Inc

第10章 セクション

  • 調査手法
  • 出版社について
目次
Product Code: CMI4248

The global reperfusion treatment market is estimated to be valued at US$ 1,546.7 Million in 2023 and is expected to exhibit a CAGR of 4.7% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1,546.7 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 4.70% 2030 Value Projection: US$ 2,135.8 Mn
Reperfusion Treatment Market - IMG1

Reperfusion therapy is used to restore blood flow in blocked arteries after a heart attack. Reperfusion injury usually occurs as a result of organ transplantation and other injuries. Patients are treated with antiplatelet therapy, open or endovascular revascularization, coronary angioplasty, and others. Reperfusion injury can occur in organs such as the heart, kidneys, liver, intestines, lungs, and brain. Clinical trials are being conducted with drugs designed to treat reflux injuries. Damage to the tissue as a result of a lack of blood supply leads to reperfusion injuries. Brain damage following a stroke is one example of a reperfusion injuries. Reperfusion therapy causes blood to flow into the tissue thatcauses inflammation and oxidative damage from oxidative stress. Therapeutic hypothermia, hydrogen sulfide therapy, cyclosporins, stem cell therapy, and other methods can all be used to treat reperfusion injury. Oxidative damage happens when reperfusion therapy is delayed.

Market Dynamics

Increasing launches of new products and mergers and acquisitions by key market players are expected to drive the global reperfusion treatment market growth. For instance, on October 15, 2021, Study.com, the extensive platform for education gainers, published an article explaining the process of delivering oxygenated blood to the body's tissues known as perfusion. Physicians must first define a few terms related to the heart beat cycle in order to comprehend when perfusion occurs. Two cycles make up one heartbeat. The first cycle, referred to as the "lub," or systole, occurs when the chambers constrict and drive blood into the arteries. The second cycle, also known as the "dub" or diastole, is when the chambers relax and blood fills them.

Key features of the study:

  • This report provides an in-depth analysis of the global reperfusion treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global reperfusion treatment market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Corline Biomedical AB, SBI Holdings Inc., Pharming Group NV, Mallinckrodt Pharmaceuticals, MIFCOR, Inc., CFM Pharma Holding B.V, Balmes Transplantation SAS, Revive Therapeutics Ltd, Faraday Pharmaceuticals, Radikal Therapeutics Inc, Amyndas Pharmaceuticals, com, Inc, Angion Biomedica Corp, Young Therapeutics, LLC, Ischemix, Stealth Biotherapeutics Inc, and Bolder Bio Technology Inc
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global reperfusion treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global reperfusion treatment market

Detailed Segmentation:

  • Global Reperfusion Treatment Market, By Treatment Type:
    • Therapeutic Hypothermia
    • Cyclosporin
    • Stem Cell Therapy
    • Hydrogen Sulphide Treatment
    • Others
  • Global Reperfusion Treatment Market, By Injury Type:
    • Heart Injury
    • Kidney Injury
    • Intestine Injury
    • Others
  • Global Reperfusion Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Others
  • Global Reperfusion Treatment Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
    • Corline Biomedical AB
    • SBI Holdings Inc.
    • Pharming Group NV
    • Mallinckrodt Pharmaceuticals
    • MIFCOR, Inc.
    • CFM Pharma Holding B.V
    • Balmes Transplantation SAS
    • Revive Therapeutics Ltd
    • Faraday Pharmaceuticals
    • Radikal Therapeutics Inc
    • Amyndas Pharmaceuticals, com, Inc.
    • Angion Biomedica Corp
    • Young Therapeutics, LLC
    • Ischemix
    • Stealth Biotherapeutics Inc
    • Bolder Bio Technology Inc

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Treatment Type
    • Market Snapshot, By Injury Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaboration
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Reperfusion Treatment Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Reperfusion Treatment Market, By Treatment Type, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Therapeutic Hypothermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Cyclosporin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Stem Cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Hydrogen Sulphide Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Reperfusion Treatment Market, By Injury Type, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Heart Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Kidney Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Intestine Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Reperfusion Treatment Market, By Distribution Channel, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Reperfusion Treatment Market, By Region, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Corline Biomedical AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • SBI Holdings Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pharming Group NV
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mallinckrodt Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • MIFCOR, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CFM Pharma Holding B.V
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Balmes Transplantation SAS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Revive Therapeutics Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Faraday Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Radikal Therapeutics Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amyndas Pharmaceuticals, com, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Angion Biomedica Corp
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Young Therapeutics, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ischemix
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Stealth Biotherapeutics Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bolder Bio Technology Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us